Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ne within Compendia and the only practical way to guarantee academic community access to these features was to take full responsibility for website support and data delivery."

"It was a big investment in both time and money, but it has always been critical to us that the academic communities have the same research capabilities as our corporate customers. We are proud that many of these new capabilities are still provided under a free research license," continued John Freshley. "Some advanced custom analyses require a license to Oncomine Research Premium Edition, but this modest investment is a tremendous value given the groundbreaking research that we and others have been able to accomplish using the premium features."

Along with expanded and new customer commitments, Compendia received an additional financial boost in 2007 when awarded a $2.4 million dollar SBIR Fast-Track award from the National Cancer Institute.

"This award was terrific validation of our approach and will allow us to truly scale the Oncomine platform in the future," said Dan Rhodes. "We have already completed the phase I feasibility portion of the award and are looking forward to rapidly executing the rest of the project."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. http://www.compendiabio.com

About Oncomine(TM)

Oncomine(TM) combines a rapidly growing compendium of 24,000+ cancer transcriptome profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates rapid and reliable biomarker and therapeutic target discovery, validation, and prioritization
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... YORK, Pa. , May 28, 2015  Unilife Corporation ... its Chairman and CEO, Alan Shortall , will present ... New York at 3:00 p.m. ET on Monday, ... be broadcast over the Internet as a "live" listen only ... archive of the event will also be available for those ...
(Date:5/28/2015)... 28, 2015 The global departmental PACS ... America , Europe , ... global departmental PACS market is expected to reach $3,807.4 million ... 2019. Browse through the TOC of global departmental ... and segments, with help of various tables and figures. ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli ... final results of the Phase III PROCLAIM trial ... presentation at the American Society of Clinical Oncology ... . PROCLAIM was a randomized, Phase III superiority ... lung cancer (NSCLC), which evaluated Lilly,s ALIMTA ® ...
Breaking Medicine Technology:Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 2Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8
... 27, 2011 Reportlinker.com announces that a new ... The 2011 Top Ten ... http://www.reportlinker.com/p0368704/The-2011-Top-Ten-World,s-Leading-Pharmaceutical-Companies.html A thought-provoking report ... major competitors in the worldwide pharmaceutical market. The ...
... 27, 2011 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin ... developer, manufacturer and seller of medicine and drugs in ... in response to recent investor interest, the Company has ... Qi local government and wishes to provide additional details ...
Cached Medicine Technology:Reportlinker Adds The 2011 Top Ten World's Leading Pharmaceutical Companies 2Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government 2
(Date:5/28/2015)... Sexual Health Innovations, a nonprofit ... health and wellbeing in the United States, announced ... (USF) will be the first institution to adopt ... reporting system. , Callisto is designed to ... experience for college sexual assault survivors, to give ...
(Date:5/28/2015)... lifeIMAGE announced today that it ... by Cambia Health Solutions (Portland, Ore.), a ... care by creating a person-focused and economically sustainable system. ... exchanging medical imaging, will use this financing to expand ... of its network capabilities and implement the next phases ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Optimity ... and implementing innovative models of care for healthcare ... support alternative reimbursements and help operationalize contracting and ... also unveils a bi-weekly series of seven “ ... Outcomes Based Contracting. Optimity is a strategy, operations ...
(Date:5/28/2015)... WebWatcher, the leading computer ... with BeSure Consulting to help parents better ... partnership will combine BeSure Consulting’s online safety ... software solution. , Led by Internet Crimes ... is concentrated on teaching law enforcement officers, ...
(Date:5/28/2015)... IL (PRWEB) May 28, 2015 Cancer ... program exhibited improvements in physical activity, fitness and quality ... Irwin of Yale Cancer Center and Jennifer Ligibel, MD, ... Women’s Cancers, Dana Farber Cancer Institute. The findings will ... Clinical Oncology (ASCO) Annual Meeting in Chicago. ...
Breaking Medicine News(10 mins):Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... sexual practices is the need of the hour rather ... challenge, according to Union Information and Broadcasting Minister S. ... to the colossal tragedy of AIDS that continues to ... to us than we realized, most people even now ...
... researchers determined Math Learning Disorder (LD) is common among school-age ... Math LD than girls. The research also indicates that although ... LD, a substantial percentage of children have Math LD alone.// ... 19 ranges from 6% to as high as 14%, depending ...
... University of Pittsburgh have successfully treated heart failure in an ... muscular dystrophy. The article detailing this study is published in ... say that this is the first time that a gene ... ,Lead author, Xiao Xiao, Ph.D., associate professor of orthopedic surgery ...
... egg should be avoided by patients with high cholesterol ... has developed a egg variety that does no ... diabetes is growing especially in Indian sub-continent. 'The modified ... S.K. Taneja, a professor in the university's Department of ...
... of these therapies against multiple myeloma (MM), relapse ... Millennium, USA) is a novel first-class agent that ... enzyme whose activity entails several molecular mechanisms, including, ... bortezomib, alone or in combination with dexamethasone and ...
... between Indian Prime Minister Dr. Manmohan Singh and Union Health ... a bird flu epidemic in India, Health Minister Anbumani Ramadoss ... bird flu in the country. Following earlier directions from WHO ... to face if there are any possible flu attack. ...
Cached Medicine News:Health News:AIDS control requires co-coordinated move regarding safe sexual practices 2Health News:Math Learning Disorder Higher In Boys 2Health News:Gene Therapy Overcomes Heart Failure In Muscular Dystrophy 2Health News:Bortezomib for salvage therapy against progressive myeloma 2Health News:Indian Health Minister interested to import bird flu vaccine 2
... Introducing the Aaron 950, the first High Frequency ... split personality. One half of the unit is ... of our very popular Aaron 900. The other ... watts of cutting power and coag capabilities ...
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: